
Metabolic Dysfunction May Better Predict Risk for HCC in Persons Cured of HCV with Advanced Fibrosis
A population-based study found metabolic dysfunction more prevalent than ultrasonographic steatosis in patients recovered from HCV and a better predictive tool for disease progression.
















